SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point Laboratories board to consider sub-division of equity shares

21 Jul 2016 Evaluate

Caplin Point Laboratories has informed that a meeting of the Board of Directors of the Company will be held on August 05, 2016, to consider the sub division of equity shares of Rs 10 each into equity shares with a lower face value. Further, the Trading Window for dealing in the equity shares of the Company is already closed for Promoters, Directors, other Connected Persons and Employees of the Company from June 20, 2016 to 48 hours after the intimation of the outcome of the above said Board Meeting to the Stock Exchanges.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Labs. Share Price

2507.25 -11.00 (-0.44%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: